Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

POSTECH

POSTECH

Sin-hyeog Im

Professor

Pohang University of Science and Technology is devoted to nurturing the leaders who make a difference globally, conducting cutting-edge research with outcomes that transform our daily lives, and directly contributing to the betterment of society through science and technology.

 

Probiotical Research

Probiotical Research

Marco Pane

R&D Director

Probiotical is an Italian family-owned company specialized since 1985 in probiotics manufacture, from the raw material to the finished products, with very high quality, guaranteed stability and scientifically backed strains. We are driving innovation in a variety of functionalities and technologies.

 

ProDigest BV

ProDigest BV

Massimo Marzorati

CEO

The most complete in vitro technology platform (from high-throughput to detailed MoA) to assess the fate of Microbiome-based medicinal products along the GI tract.

 

PROGE FARM S.r.l.

PROGE FARM S.r.l.

Antonella Bonetti

Regulatory Affairs Manager

PROGE FARM develops, produces, registers (even as medicine) and put on the markets, directly or through licensees, its products based on selected patented probiotic strains.

 

Quadram Institute

Quadram Institute

Graeme Brown

CBO

At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia (UEA).

 

Recolony

Recolony

Ana Montalban-Arques

CEO Recolony

Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer.

 

Sandwalk BioVentures

Sandwalk BioVentures

Luis Gosalbez

Founder & CEO

Sandwalk BioVentures is an end-to-end innovation, strategy, regulatory intelligence and management consulting firm that provides tailored, turnkey solutions to life sciences companies and investors.

 

Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

Ann Kurowski

Vice President Regulatory Affairs

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.